The increasing awareness of the significance of microbial biofilms across different sectors is
continuously revealing new areas of opportunity in the development of innovative …

Cardiac implantable electronic device (CIED) infection is a potentially devastating
complication of CIED procedures, causing significant morbidity and mortality for patients. Of …

Infection remains a serious complication associated with the cardiac implantable electronic
devices (CIEDs), leading to substantial clinical and economic burden globally. This review …

Abstract Aim The Prevention of Arrhythmia Device Infection Trial (PADIT) infection risk score,
developed based on a large prospectively collected data set, identified five independent …

Objectives To model the cost-effectiveness of the TYRX Absorbable Antibacterial Envelope
when used in patients at increased risk of cardiac implantable electronic device (CIED) …

The implantation of cardiac electronic devices (CIEDs), including pacemakers and
defibrillators, has become increasingly prevalent in recent years and has been …

Background: In the WRAP-IT trial (Worldwide Randomized Antibiotic Envelope Infection
Prevention), adjunctive use of an absorbable antibacterial envelope resulted in a 40 …

Aims Use of an absorbable antibacterial envelope during implantation prevents cardiac
implantable electronic device infections in patients with a moderate-to-high infection risk …

Aims Cardiac implantable electronic device (CIED) infections are a burden to hospitals and
costly for healthcare systems. Chronic kidney disease (CKD) increases the risk of CIED …

Purpose Despite the unparalleled importance of value within healthcare, value-based
models remain underutilised in the procurement of medical devices. Research is needed to …